Vista Pharmaceuticals has informed that it enclosed 32nd Annual Report for the Financial Year 2022-2023 along with Notice of the Annual General Meeting to be held on Saturday, 30th day of September, 2023 at 11.00 AM through Video Conferencing (VC)/ Other Audio-Visual Means (OAVM). The Notice, together with the Annual Report for the year 2022-23, is being sent only in electronic form, in accordance with the relaxation granted by the SEBI vide Circular dated 15th January, 2021, 13th May, 2022 and 5th January, 2023 to all the shareholders whose names appear on the Register of Members/ list of Beneficial Owners as received from National Securities Depository (NSDL)/ Central Depository Services (India) (CDSL) as at the close of business hours on 1st September, 2023 and who have registered their email id with the Company/ Depositories.
The above information is a part of company’s filings submitted to BSE.